Back to results
US 2008/0176903 A1Published application
Novel Compounds with Analgesic Effect
AssigneeAstraZeneca Canada Inc.
InventorsDaniel Delorme, Edward Roberts, Zhongyong Wei
Life of this patent
Estimating the term…
Abstract
Compounds of general formula (I) are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the management of pain.
Claims21
1-26. (canceled)
A compound of the general formula (I)
- wherein
- R1 is hydrogen, a branched or straight C1-C6alkyl, C1-C6alkenyl, C3-C8cycloalkyl, (C1-C2alkyl)-(C3-C6cycloalkyl), C6-C10aryl, heteroaryl, (C1-C2 alkyl)-(C6-C10 aryl), (C1-C2 alkyl)heteroaryl,
- wherein said heteroaryl has from 5 to 10 atoms selected from C, S, N and/or O and wherein said aryl and/or heteroaryl may optionally and independently be substituted by 1 or 2 substituents selected from hydrogen, CH3, —(CH2)qCF3, halogen, —CONR5R4, —COOR5, —COR5, —(CH2)qNR5R4, —(CH2)qCH3, —(CH2)qSOR5, —(CH2)qSO2R5, —(CH2)qSO2NR5R4, and —(CH2)qOR5, wherein q is 0, 1 or 2;
- R2 and R3 is each and independently selected from hydrogen and C1-C6alkyl;
- A is
- Z1 and Z2 is each independently selected from hydrogen, CH3, —(CH2)rCF3, halogen, —CONR6R7, —CO2R6, —COR6, —(CH2)rNR6R7, —(CH2)rCH3, —(CH2)rSOR6, —(CH2)rSO2R6 and —(CH2)rSO2NR6R7, wherein r is 0, 1, or 2;
- B is phenyl or naphthyl, wherein the phenyl and naphthyl is optionally and independently substituted by 1 or 2 substituents selected from hydrogen, CH3, —(CH2)tCF3, halogen, —(CH2)tCONR5R4, —(CH2)tNR5R4, —(CH2)tCOR5, —(CH2)tCOOR5, —OR5, —(CH2)tSOR5, —(CH2)tSO2R5, and —(CH2)tSO2NR5R4, wherein t is 0, 1, 2 or 3;
- R4, R5, R6, and R7 is each independently selected from hydrogen, a branched or straight C1-C6alkyl, C1-C6alkenyl, C3-C8cycloalkyl, and (C1-C2alkyl)-(C3-C6cycloalkyl);
- R12 and R13 is each independently selected from hydrogen, a branched or straight C1-C6 alkyl, C1-C6alkenyl, C3-C8cycloalkyl, (C1-C2alkyl)-(C3-C6cycloalkyl), and O—C1-C3alkyl;
- and
- R18, R19, R20, R21, R22, R23, and R24 is each independently selected from hydrogen, C1-C6alkyl, and C1-C6alkenyl;
- as well as pharmaceutically acceptable salts thereof.
9 more elements
Dependencies are inferred from the claim text.